[Immunology] Immunosuppressive therapy mitigates immunological rejection of human embryonic stem...

‡R.-J.S. and S.S. contributed equally to this work. (received for review January 29, 2008) Abstract Given their self-renewing and pluripotent capabilities, human embryonic stem cells (hESCs) are well poised as a cellular source for tissue regeneration therapy. However, the host immune response against transplanted hESCs is not well characterized. In fact, controversy remains as to whether hESCs have... [read full story]